Table 3.

Clinical data of patients with recurrent disease

Number	Gender	Stage	Exon	Duration of treatment	Sites of recurrence	DFS (months)
1	F	IIIa	21	13	Lymph nodes	13
2	M	II	21	18	Lung	27
3	M	IIIa	19	12	Brain, bone, and liver	12
4	M	II	21	12	Liver	12
5	M	II	19	18	Contralateral lung	33

DFS, disease‐free survival; F, female; M, male.